LEAP a New Overground Body Weight Support Robot: Usability Trial (LEAP)
Primary Purpose
Spinal Cord Injuries, Cerebral Palsy, Parkinson Disease
Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Therapist LEAP session feedback
Participant LEAP session feedback
LEAP risk control validation
Sponsored by
About this trial
This is an interventional other trial for Spinal Cord Injuries
Eligibility Criteria
Healthy participants fulfilling all of the following inclusion criteria are eligible for the study:
- The healthy volunteer or legal representative has been informed and has signed the informed consent form
- Age 18-80 or age 5-10 (women or men)
- Weight below 137 kg
- Height between 120 and 190 cm
- Agree to comply in good faith with all conditions of the study and to attend all required training
Patients fulfilling all of the following inclusion criteria are eligible for the study:
- The patient has been informed and has signed the informed consent form
- Age 18-80 (women or men)
- Weight below 137 kg
- Height between 120 and 190 cm
- Neurological/musculoskeletal diagnoses
- Impairment of the lower extremities
- Stable medical and physical condition as considered by the attending doctor or physician
- Agree to comply in good faith with all conditions of the study and to attend all required training
- Other (non-neurological) diagnoses, who require intense training of the lower extremities
- The rehabilitation physician or doctor provides a final agreement whether the participant can train with the LEAP
The presence of any one of the following exclusion criteria will lead to exclusion of the participant, for example:
- Strong adipositas, which makes it not possible to adjust the harness to the anthropometrics of the participant
- Bracing of the spinal column.
- Severe joint contractures disabling or restricting lower limb movements
- Instabilities of bones or joints, fractures or osteoporosis/osteopenia
- Allergy against material of harness
- Open skin lesions
- Luxations or subluxations of joints that should be positioned in LEAP
- Strong pain
- Strong spontaneous movements like ataxia, dyskinesia, myoclonus*
- Instable vital functions like pulmonal or cardiovascular conditions
- Uncooperative or aggressive behaviour
- Severe cognitive deficits
- Inability to signal pain or discomfort
- Apraxia*
- Severe spasticity (Ashworth 4)
- Severe epilepsy*
- Insufficient head stability
- Infections requiring isolation of the patient
- History of significant autonomic dysreflexia
- Systemic malignant disorders
- Cardiovascular disorders restricting physical training
- Peripheral nerve disorders
- Other anatomic or co-morbid conditions that, in the investigator's opinion, could limit the patient's ability to participate in the study or to comply with follow-up requirements, or impact the scientific soundness of the study results.
- Known or suspected non-compliance, drug or alcohol abuse,
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant,
- Participation in another study with investigational drug within the 30 days preceding and during the present study
- Previous enrolment into the current study Contraindications marked with an * are relative contraindications. Final approval needs to be obtained from the attending medical doctor.
Sites / Locations
- Clinique Romande de Réadaptation (CRR), SUVAcare
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
LEAP usability
Arm Description
Therapist LEAP session feedback Participant LEAP session feedback LEAP risk control validation
Outcomes
Primary Outcome Measures
Usability of the robot - Fixation
From the user/therapist the information on the usability of the robot (CRF I) is being assessed. This questionnaire is only filled once by each user/therapist.
Feedback on patient/subject fixation (Ordinal scale from 1:useful to 5:not useful)
Usability of the robot - Applicability
From the user/therapist the information on the usability of the robot (CRF I) is being assessed. This questionnaire is only filled once by each user/therapist.
Feedback on clinical applicability (Ordinal scale from 1:useful to 5:not useful)
Usability of the robot - Robot support
From the user/therapist the information on the usability of the robot (CRF I) is being assessed. This questionnaire is only filled once by each user/therapist.
Feedback on robot support (Ordinal scale from 1:useful to 5:not useful)
Usability of the robot - User interface
From the user/therapist the information on the usability of the robot (CRF I) is being assessed. This questionnaire is only filled once by each user/therapist.
Feedback on user interface (Graphical user interface) (Ordinal scale from 1:useful to 5:not useful)
Usability of the robot - Interaction
From the user/therapist the information on the usability of the robot (CRF I) is being assessed. This questionnaire is only filled once by each user/therapist.
Feedback on the LEAP interaction (Ordinal scale from 1:useful to 5:not useful)
Risk control validation - Observer
From an independent observer (investigator, or a member of the development team) the occurrence of use errors is recorded (CRF III):
Each primary operating function of the robot is rated (Ordinal scale from 0 to 1 for 'use error occurred' or 'no use error' This questionnaire has only to be filled out once for each user/therapist.
Risk control validation - User
The risk control measures are validated by the user/therapist (CRF IV):
The different risk controls are rated (Ordinal scale from 0 to 1 for 'Acceptable' or 'Not acceptable') This questionnaire has only to be filled out once by each user/therapist.
Participant feeling of safety/comfort - Fixation
From the participant information on the comfort/safety is being assessed (CRF II):
Feedback on the fixation of the patient (Open-ended question)
Participant feeling of safety/comfort - Robot training
From the participant information on the comfort/safety is being assessed (CRF II):
Feedback on the robot training (Ordinal scale from 0 to 5)
Participant feeling of safety/comfort - Robot support
From the participant information on the comfort/safety is being assessed (CRF II):
Feedback on the robot support (Ordinal scale from 0 to 5)
Secondary Outcome Measures
Robot Measurement - Patient position
The robot records the patient position in the room (in meters).
Robot Measurement - Walking speed
The robot records the walking speed (in meters per second).
Robot Measurement - Occurred errors
The robot records the errors occurred (error number).
Robot Measurement - Support forces
The robot records the support forces (in Newton).
Robot Measurement - Fall detection
The robot records the number of detected falls (Amount of detected falls).
Robot Measurement - Walked distance
The robot records the distance the patient walked during the session (in meters).
EMG system
Upon availability, an EMG system will be used to measure muscle activity during the session.
Patient characteristics - Testing date
The testing date (day/month/year) is being recorded.
Patient characteristics - Identification number
A unique participant identification number is being recorded.
Patient characteristics - Body height
The body height (in cm) is being recorded.
Patient characteristics - Body weight
The body weight (in kg) is being recorded.
Patient characteristics - Waist size
The waist size (in cm) is being recorded.
Patient characteristics - Tight circumference
The tight circumference (in cm) is being recorded.
Patient characteristics - Chest size
The chest size (in cm) is being recorded.
Patient characteristics - Age
The following patient characteristic is being transferred from the clinical internal database (obtained in the CRR on a regular basis): The age of the participant (in years, decimal) is being recorded.
Patient characteristics - Stationary or ambulant
The following patient characteristic is being transferred from the clinical internal database (obtained in the CRR on a regular basis): It will be recorded whether the patient is stationary or ambulant.
Patient characteristics - Dominant side
The following patient characteristic is being transferred from the clinical internal database (obtained in the CRR on a regular basis): The dominant body side (left or right) is being recorded.
Patient characteristics - Walking aid
The following patient characteristic is being transferred from the clinical internal database (obtained in the CRR on a regular basis):
If applicable: The type of walking aid (open-ended question) is being recorded.
Patient characteristics - Six minute walking test
The following patient characteristic is being transferred from the clinical internal database (obtained in the CRR on a regular basis): Upon availability the outcome of the Six-minute walking test will be recorded (distance in meters. Longer distance corresponds to a better outcome.).
Patient characteristics - BAECKE score
The following patient characteristic is being transferred from the clinical internal database (obtained in the CRR on a regular basis): BAECKE physical activity questionnaire (Score between 0: no activity, and 10: high activity).
Patient characteristics - Fugl-Meyer score
The following patient characteristic is being transferred from the clinical internal database (obtained in the CRR on a regular basis): Lower limb subset of the Fugl-Meyer score. Fugl-Meyer assessment measures the sensorimotor function. (Score between 0: no function and 34: full functionality).
Full Information
NCT ID
NCT03458169
First Posted
December 21, 2017
Last Updated
January 29, 2019
Sponsor
Clinique Romande de Readaptation
1. Study Identification
Unique Protocol Identification Number
NCT03458169
Brief Title
LEAP a New Overground Body Weight Support Robot: Usability Trial
Acronym
LEAP
Official Title
Usability of a New Overground Body Weight Support Rehabilitation Robot LEAP: A Monocentric Consideration-of-concept Trial
Study Type
Interventional
2. Study Status
Record Verification Date
March 2018
Overall Recruitment Status
Completed
Study Start Date
January 1, 2018 (Actual)
Primary Completion Date
April 30, 2018 (Actual)
Study Completion Date
April 30, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Clinique Romande de Readaptation
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
People with central nervous system disorders such as spinal cord injury, stroke, cerebral palsy, Parkinson's disease, multiple sclerosis, etc… often have impaired lower extremity function that limits activities of daily life and independence. Different body-weight support systems have been developed to facilitate the rehabilitation process by compensating for the user's residual abilities. However, studies on weight-supported gait training on a treadmill have failed to show superiority over conventional rehabilitation programs for spinal cord injury and stroke. A recent study by the group around Grégoire Courtine showed that body-weight support systems that provide assistance only in the vertical direction disrupt the production of gait and balance, suggesting that current practices may even be detrimental for relearning to walk. For the past year, the Clinique Romande de Réadaptation (CRR) worked together with the G-Lab at EPFL and G-Therapeutics on a new robot platform specifically developed to provide adjustable trunk support along four independent degrees of freedom (LEAP). The investigators were able to draw on their long-term experience, which consists of different body weight support training systems for stroke and spinal cord injury. This knowledge, combined with the input of our therapists and physicians and the specific requirements for people with neurological/musculoskeletal disorders, has resulted in a design that can provide adjustable bodyweight support during over-ground locomotion, treadmill, stairs training, standing up and sitting down and for support during the training of activities of daily living.
The scope of this study is to examine how well the robot can be used for rehabilitation therapy in everyday clinical practice. This includes, among other things, technical aspects such as the handling of the hardware, the adaptability of the robot to the patient, and the safety during operation (such as the fall prevention). Various patient-specific aspects will also be evaluated e.g. comfort, positioning, or motivation of the patient. This study also aims to evaluate the software with the various support modes, operating options, and the user interface of the LEAP.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Spinal Cord Injuries, Cerebral Palsy, Parkinson Disease, Multiple Sclerosis, Stroke, People With Impaired Lower Extremity Function
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
43 (Actual)
8. Arms, Groups, and Interventions
Arm Title
LEAP usability
Arm Type
Experimental
Arm Description
Therapist LEAP session feedback
Participant LEAP session feedback
LEAP risk control validation
Intervention Type
Device
Intervention Name(s)
Therapist LEAP session feedback
Intervention Description
A standard therapy session is being performed with a participant with the LEAP body-weight support robot. Subsequently, the therapist is answering a questionnaire to assess the clinical applicability of the robot. An observer will assess with a questionnaire whether use errors occurred during the session.
Intervention Type
Device
Intervention Name(s)
Participant LEAP session feedback
Intervention Description
A standard therapy session is being performed with a participant inside the LEAP body-weight support robot. Subsequently, the participant is answering a questionnaire to assess the comfort of the robot.
Intervention Type
Device
Intervention Name(s)
LEAP risk control validation
Intervention Description
The therapist rates the risk control measurements of the LEAP robot with a questionnaire, during a session with a member of the investigational team.
Primary Outcome Measure Information:
Title
Usability of the robot - Fixation
Description
From the user/therapist the information on the usability of the robot (CRF I) is being assessed. This questionnaire is only filled once by each user/therapist.
Feedback on patient/subject fixation (Ordinal scale from 1:useful to 5:not useful)
Time Frame
2 minutes
Title
Usability of the robot - Applicability
Description
From the user/therapist the information on the usability of the robot (CRF I) is being assessed. This questionnaire is only filled once by each user/therapist.
Feedback on clinical applicability (Ordinal scale from 1:useful to 5:not useful)
Time Frame
2 minutes
Title
Usability of the robot - Robot support
Description
From the user/therapist the information on the usability of the robot (CRF I) is being assessed. This questionnaire is only filled once by each user/therapist.
Feedback on robot support (Ordinal scale from 1:useful to 5:not useful)
Time Frame
2 minutes
Title
Usability of the robot - User interface
Description
From the user/therapist the information on the usability of the robot (CRF I) is being assessed. This questionnaire is only filled once by each user/therapist.
Feedback on user interface (Graphical user interface) (Ordinal scale from 1:useful to 5:not useful)
Time Frame
2 minutes
Title
Usability of the robot - Interaction
Description
From the user/therapist the information on the usability of the robot (CRF I) is being assessed. This questionnaire is only filled once by each user/therapist.
Feedback on the LEAP interaction (Ordinal scale from 1:useful to 5:not useful)
Time Frame
2 minutes
Title
Risk control validation - Observer
Description
From an independent observer (investigator, or a member of the development team) the occurrence of use errors is recorded (CRF III):
Each primary operating function of the robot is rated (Ordinal scale from 0 to 1 for 'use error occurred' or 'no use error' This questionnaire has only to be filled out once for each user/therapist.
Time Frame
1 hour
Title
Risk control validation - User
Description
The risk control measures are validated by the user/therapist (CRF IV):
The different risk controls are rated (Ordinal scale from 0 to 1 for 'Acceptable' or 'Not acceptable') This questionnaire has only to be filled out once by each user/therapist.
Time Frame
1 hour
Title
Participant feeling of safety/comfort - Fixation
Description
From the participant information on the comfort/safety is being assessed (CRF II):
Feedback on the fixation of the patient (Open-ended question)
Time Frame
1 minute
Title
Participant feeling of safety/comfort - Robot training
Description
From the participant information on the comfort/safety is being assessed (CRF II):
Feedback on the robot training (Ordinal scale from 0 to 5)
Time Frame
1 minute
Title
Participant feeling of safety/comfort - Robot support
Description
From the participant information on the comfort/safety is being assessed (CRF II):
Feedback on the robot support (Ordinal scale from 0 to 5)
Time Frame
1 minute
Secondary Outcome Measure Information:
Title
Robot Measurement - Patient position
Description
The robot records the patient position in the room (in meters).
Time Frame
1 hour
Title
Robot Measurement - Walking speed
Description
The robot records the walking speed (in meters per second).
Time Frame
1 hour
Title
Robot Measurement - Occurred errors
Description
The robot records the errors occurred (error number).
Time Frame
1 hour
Title
Robot Measurement - Support forces
Description
The robot records the support forces (in Newton).
Time Frame
1 hour
Title
Robot Measurement - Fall detection
Description
The robot records the number of detected falls (Amount of detected falls).
Time Frame
1 hour
Title
Robot Measurement - Walked distance
Description
The robot records the distance the patient walked during the session (in meters).
Time Frame
1 hour
Title
EMG system
Description
Upon availability, an EMG system will be used to measure muscle activity during the session.
Time Frame
1 hour
Title
Patient characteristics - Testing date
Description
The testing date (day/month/year) is being recorded.
Time Frame
1 minutes
Title
Patient characteristics - Identification number
Description
A unique participant identification number is being recorded.
Time Frame
1 minutes
Title
Patient characteristics - Body height
Description
The body height (in cm) is being recorded.
Time Frame
1 minutes
Title
Patient characteristics - Body weight
Description
The body weight (in kg) is being recorded.
Time Frame
1 minutes
Title
Patient characteristics - Waist size
Description
The waist size (in cm) is being recorded.
Time Frame
1 minutes
Title
Patient characteristics - Tight circumference
Description
The tight circumference (in cm) is being recorded.
Time Frame
1 minutes
Title
Patient characteristics - Chest size
Description
The chest size (in cm) is being recorded.
Time Frame
1 minutes
Title
Patient characteristics - Age
Description
The following patient characteristic is being transferred from the clinical internal database (obtained in the CRR on a regular basis): The age of the participant (in years, decimal) is being recorded.
Time Frame
1 minutes
Title
Patient characteristics - Stationary or ambulant
Description
The following patient characteristic is being transferred from the clinical internal database (obtained in the CRR on a regular basis): It will be recorded whether the patient is stationary or ambulant.
Time Frame
1 minutes
Title
Patient characteristics - Dominant side
Description
The following patient characteristic is being transferred from the clinical internal database (obtained in the CRR on a regular basis): The dominant body side (left or right) is being recorded.
Time Frame
1 minutes
Title
Patient characteristics - Walking aid
Description
The following patient characteristic is being transferred from the clinical internal database (obtained in the CRR on a regular basis):
If applicable: The type of walking aid (open-ended question) is being recorded.
Time Frame
1 minutes
Title
Patient characteristics - Six minute walking test
Description
The following patient characteristic is being transferred from the clinical internal database (obtained in the CRR on a regular basis): Upon availability the outcome of the Six-minute walking test will be recorded (distance in meters. Longer distance corresponds to a better outcome.).
Time Frame
1 minutes
Title
Patient characteristics - BAECKE score
Description
The following patient characteristic is being transferred from the clinical internal database (obtained in the CRR on a regular basis): BAECKE physical activity questionnaire (Score between 0: no activity, and 10: high activity).
Time Frame
1 minutes
Title
Patient characteristics - Fugl-Meyer score
Description
The following patient characteristic is being transferred from the clinical internal database (obtained in the CRR on a regular basis): Lower limb subset of the Fugl-Meyer score. Fugl-Meyer assessment measures the sensorimotor function. (Score between 0: no function and 34: full functionality).
Time Frame
1 minutes
10. Eligibility
Sex
All
Minimum Age & Unit of Time
5 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Healthy participants fulfilling all of the following inclusion criteria are eligible for the study:
The healthy volunteer or legal representative has been informed and has signed the informed consent form
Age 18-80 or age 5-10 (women or men)
Weight below 137 kg
Height between 120 and 190 cm
Agree to comply in good faith with all conditions of the study and to attend all required training
Patients fulfilling all of the following inclusion criteria are eligible for the study:
The patient has been informed and has signed the informed consent form
Age 18-80 (women or men)
Weight below 137 kg
Height between 120 and 190 cm
Neurological/musculoskeletal diagnoses
Impairment of the lower extremities
Stable medical and physical condition as considered by the attending doctor or physician
Agree to comply in good faith with all conditions of the study and to attend all required training
Other (non-neurological) diagnoses, who require intense training of the lower extremities
The rehabilitation physician or doctor provides a final agreement whether the participant can train with the LEAP
The presence of any one of the following exclusion criteria will lead to exclusion of the participant, for example:
Strong adipositas, which makes it not possible to adjust the harness to the anthropometrics of the participant
Bracing of the spinal column.
Severe joint contractures disabling or restricting lower limb movements
Instabilities of bones or joints, fractures or osteoporosis/osteopenia
Allergy against material of harness
Open skin lesions
Luxations or subluxations of joints that should be positioned in LEAP
Strong pain
Strong spontaneous movements like ataxia, dyskinesia, myoclonus*
Instable vital functions like pulmonal or cardiovascular conditions
Uncooperative or aggressive behaviour
Severe cognitive deficits
Inability to signal pain or discomfort
Apraxia*
Severe spasticity (Ashworth 4)
Severe epilepsy*
Insufficient head stability
Infections requiring isolation of the patient
History of significant autonomic dysreflexia
Systemic malignant disorders
Cardiovascular disorders restricting physical training
Peripheral nerve disorders
Other anatomic or co-morbid conditions that, in the investigator's opinion, could limit the patient's ability to participate in the study or to comply with follow-up requirements, or impact the scientific soundness of the study results.
Known or suspected non-compliance, drug or alcohol abuse,
Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant,
Participation in another study with investigational drug within the 30 days preceding and during the present study
Previous enrolment into the current study Contraindications marked with an * are relative contraindications. Final approval needs to be obtained from the attending medical doctor.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Urs Keller, PhD
Organizational Affiliation
Ecole Polytechnique Fédérale de Lausanne
Official's Role
Principal Investigator
Facility Information:
Facility Name
Clinique Romande de Réadaptation (CRR), SUVAcare
City
Sion
State/Province
Valais
ZIP/Postal Code
1951
Country
Switzerland
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
21586596
Citation
Freund P, Weiskopf N, Ward NS, Hutton C, Gall A, Ciccarelli O, Craggs M, Friston K, Thompson AJ. Disability, atrophy and cortical reorganization following spinal cord injury. Brain. 2011 Jun;134(Pt 6):1610-22. doi: 10.1093/brain/awr093. Epub 2011 May 17.
Results Reference
background
PubMed Identifier
10896007
Citation
Kennedy P, Rogers BA. Anxiety and depression after spinal cord injury: a longitudinal analysis. Arch Phys Med Rehabil. 2000 Jul;81(7):932-7. doi: 10.1053/apmr.2000.5580.
Results Reference
background
PubMed Identifier
10917267
Citation
Fehr L, Langbein WE, Skaar SB. Adequacy of power wheelchair control interfaces for persons with severe disabilities: a clinical survey. J Rehabil Res Dev. 2000 May-Jun;37(3):353-60.
Results Reference
background
PubMed Identifier
15520982
Citation
Hunt PC, Boninger ML, Cooper RA, Zafonte RD, Fitzgerald SG, Schmeler MR. Demographic and socioeconomic factors associated with disparity in wheelchair customizability among people with traumatic spinal cord injury. Arch Phys Med Rehabil. 2004 Nov;85(11):1859-64. doi: 10.1016/j.apmr.2004.07.347.
Results Reference
background
PubMed Identifier
25311847
Citation
Meyns P, Van de Crommert HW, Rijken H, van Kuppevelt DH, Duysens J. Locomotor training with body weight support in SCI: EMG improvement is more optimally expressed at a low testing speed. Spinal Cord. 2014 Dec;52(12):887-93. doi: 10.1038/sc.2014.172. Epub 2014 Oct 14.
Results Reference
background
PubMed Identifier
11552877
Citation
Crompton S, Khemlani M, Batty J, Ada L, Dean C, Katrak P. Practical issues in retraining walking in severely disabled patients using treadmill and harness support systems. Aust J Physiother. 2001;47(3):211-3. doi: 10.1016/s0004-9514(14)60268-3. No abstract available.
Results Reference
background
PubMed Identifier
20549154
Citation
Wessels M, Lucas C, Eriks I, de Groot S. Body weight-supported gait training for restoration of walking in people with an incomplete spinal cord injury: a systematic review. J Rehabil Med. 2010 Jun;42(6):513-9. doi: 10.2340/16501977-0525.
Results Reference
background
PubMed Identifier
17172551
Citation
Dobkin B, Barbeau H, Deforge D, Ditunno J, Elashoff R, Apple D, Basso M, Behrman A, Harkema S, Saulino M, Scott M; Spinal Cord Injury Locomotor Trial Group. The evolution of walking-related outcomes over the first 12 weeks of rehabilitation for incomplete traumatic spinal cord injury: the multicenter randomized Spinal Cord Injury Locomotor Trial. Neurorehabil Neural Repair. 2007 Jan-Feb;21(1):25-35. doi: 10.1177/1545968306295556.
Results Reference
background
PubMed Identifier
19556526
Citation
Franceschini M, Carda S, Agosti M, Antenucci R, Malgrati D, Cisari C; Gruppo Italiano Studio Allevio Carico Ictus. Walking after stroke: what does treadmill training with body weight support add to overground gait training in patients early after stroke?: a single-blind, randomized, controlled trial. Stroke. 2009 Sep;40(9):3079-85. doi: 10.1161/STROKEAHA.109.555540. Epub 2009 Jun 25.
Results Reference
background
PubMed Identifier
21954995
Citation
Hoyer E, Jahnsen R, Stanghelle JK, Strand LI. Body weight supported treadmill training versus traditional training in patients dependent on walking assistance after stroke: a randomized controlled trial. Disabil Rehabil. 2012;34(3):210-9. doi: 10.3109/09638288.2011.593681.
Results Reference
background
PubMed Identifier
14586916
Citation
Ada L, Dean CM, Hall JM, Bampton J, Crompton S. A treadmill and overground walking program improves walking in persons residing in the community after stroke: a placebo-controlled, randomized trial. Arch Phys Med Rehabil. 2003 Oct;84(10):1486-91. doi: 10.1016/s0003-9993(03)00349-6.
Results Reference
background
PubMed Identifier
11228945
Citation
Kosak MC, Reding MJ. Comparison of partial body weight-supported treadmill gait training versus aggressive bracing assisted walking post stroke. Neurorehabil Neural Repair. 2000;14(1):13-9. doi: 10.1177/154596830001400102.
Results Reference
background
PubMed Identifier
9626282
Citation
Visintin M, Barbeau H, Korner-Bitensky N, Mayo NE. A new approach to retrain gait in stroke patients through body weight support and treadmill stimulation. Stroke. 1998 Jun;29(6):1122-8. doi: 10.1161/01.str.29.6.1122.
Results Reference
background
PubMed Identifier
11392657
Citation
Teixeira da Cunha Filho I, Lim PA, Qureshy H, Henson H, Monga T, Protas EJ. A comparison of regular rehabilitation and regular rehabilitation with supported treadmill ambulation training for acute stroke patients. J Rehabil Res Dev. 2001 Mar-Apr;38(2):245-55.
Results Reference
background
PubMed Identifier
12468788
Citation
Werner C, Von Frankenberg S, Treig T, Konrad M, Hesse S. Treadmill training with partial body weight support and an electromechanical gait trainer for restoration of gait in subacute stroke patients: a randomized crossover study. Stroke. 2002 Dec;33(12):2895-901. doi: 10.1161/01.str.0000035734.61539.f6.
Results Reference
background
PubMed Identifier
11594641
Citation
Nilsson L, Carlsson J, Danielsson A, Fugl-Meyer A, Hellstrom K, Kristensen L, Sjolund B, Sunnerhagen KS, Grimby G. Walking training of patients with hemiparesis at an early stage after stroke: a comparison of walking training on a treadmill with body weight support and walking training on the ground. Clin Rehabil. 2001 Oct;15(5):515-27. doi: 10.1191/026921501680425234.
Results Reference
background
PubMed Identifier
17895349
Citation
Sullivan KJ, Brown DA, Klassen T, Mulroy S, Ge T, Azen SP, Winstein CJ; Physical Therapy Clinical Research Network (PTClinResNet). Effects of task-specific locomotor and strength training in adults who were ambulatory after stroke: results of the STEPS randomized clinical trial. Phys Ther. 2007 Dec;87(12):1580-602. doi: 10.2522/ptj.20060310. Epub 2007 Sep 25.
Results Reference
background
PubMed Identifier
23599221
Citation
Mackay-Lyons M, McDonald A, Matheson J, Eskes G, Klus MA. Dual effects of body-weight supported treadmill training on cardiovascular fitness and walking ability early after stroke: a randomized controlled trial. Neurorehabil Neural Repair. 2013 Sep;27(7):644-53. doi: 10.1177/1545968313484809. Epub 2013 Apr 18.
Results Reference
background
PubMed Identifier
24519922
Citation
Combs-Miller SA, Kalpathi Parameswaran A, Colburn D, Ertel T, Harmeyer A, Tucker L, Schmid AA. Body weight-supported treadmill training vs. overground walking training for persons with chronic stroke: a pilot randomized controlled trial. Clin Rehabil. 2014 Sep;28(9):873-84. doi: 10.1177/0269215514520773. Epub 2014 Feb 11.
Results Reference
background
PubMed Identifier
22809736
Citation
Combs SA, Dugan EL, Ozimek EN, Curtis AB. Effects of body-weight supported treadmill training on kinetic symmetry in persons with chronic stroke. Clin Biomech (Bristol, Avon). 2012 Nov;27(9):887-92. doi: 10.1016/j.clinbiomech.2012.06.011. Epub 2012 Jul 17.
Results Reference
background
PubMed Identifier
20149244
Citation
Burgess JK, Weibel GC, Brown DA. Overground walking speed changes when subjected to body weight support conditions for nonimpaired and post stroke individuals. J Neuroeng Rehabil. 2010 Feb 11;7:6. doi: 10.1186/1743-0003-7-6.
Results Reference
background
PubMed Identifier
15472095
Citation
Lamontagne A, Fung J. Faster is better: implications for speed-intensive gait training after stroke. Stroke. 2004 Nov;35(11):2543-8. doi: 10.1161/01.STR.0000144685.88760.d7. Epub 2004 Oct 7.
Results Reference
background
PubMed Identifier
19951435
Citation
Sousa CO, Barela JA, Prado-Medeiros CL, Salvini TF, Barela AM. The use of body weight support on ground level: an alternative strategy for gait training of individuals with stroke. J Neuroeng Rehabil. 2009 Dec 1;6:43. doi: 10.1186/1743-0003-6-43.
Results Reference
background
PubMed Identifier
24419023
Citation
Swinnen E, Baeyens JP, Pintens S, Van Nieuwenhoven J, Ilsbroukx S, Clijsen R, Buyl R, Goossens M, Meeusen R, Kerckhofs E. Trunk muscle activity during walking in persons with multiple sclerosis: the influence of body weight support. NeuroRehabilitation. 2014;34(2):323-35. doi: 10.3233/NRE-131044.
Results Reference
background
PubMed Identifier
24187306
Citation
Pennycott A, Vallery H, Wyss D, Spindler M, Dewarrat A, Riener R. A novel body weight support system extension: initial concept and simulation study. IEEE Int Conf Rehabil Robot. 2013 Jun;2013:6650489. doi: 10.1109/ICORR.2013.6650489.
Results Reference
background
PubMed Identifier
8234761
Citation
Winter DA, MacKinnon CD, Ruder GK, Wieman C. An integrated EMG/biomechanical model of upper body balance and posture during human gait. Prog Brain Res. 1993;97:359-67. doi: 10.1016/s0079-6123(08)62295-5.
Results Reference
background
PubMed Identifier
22654062
Citation
van den Brand R, Heutschi J, Barraud Q, DiGiovanna J, Bartholdi K, Huerlimann M, Friedli L, Vollenweider I, Moraud EM, Duis S, Dominici N, Micera S, Musienko P, Courtine G. Restoring voluntary control of locomotion after paralyzing spinal cord injury. Science. 2012 Jun 1;336(6085):1182-5. doi: 10.1126/science.1217416.
Results Reference
background
PubMed Identifier
26428035
Citation
Awai L, Bolliger M, Ferguson AR, Courtine G, Curt A. Influence of Spinal Cord Integrity on Gait Control in Human Spinal Cord Injury. Neurorehabil Neural Repair. 2016 Jul;30(6):562-72. doi: 10.1177/1545968315600524. Epub 2015 Oct 1.
Results Reference
background
PubMed Identifier
24627428
Citation
Straube DD, Holleran CL, Kinnaird CR, Leddy AL, Hennessy PW, Hornby TG. Effects of dynamic stepping training on nonlocomotor tasks in individuals poststroke. Phys Ther. 2014 Jul;94(7):921-33. doi: 10.2522/ptj.20130544. Epub 2014 Mar 13.
Results Reference
background
PubMed Identifier
26860920
Citation
von Zitzewitz J, Asboth L, Fumeaux N, Hasse A, Baud L, Vallery H, Courtine G. A neurorobotic platform for locomotor prosthetic development in rats and mice. J Neural Eng. 2016 Apr;13(2):026007. doi: 10.1088/1741-2560/13/2/026007. Epub 2016 Feb 10.
Results Reference
background
PubMed Identifier
22653117
Citation
Dominici N, Keller U, Vallery H, Friedli L, van den Brand R, Starkey ML, Musienko P, Riener R, Courtine G. Versatile robotic interface to evaluate, enable and train locomotion and balance after neuromotor disorders. Nat Med. 2012 Jul;18(7):1142-7. doi: 10.1038/nm.2845.
Results Reference
background
PubMed Identifier
25253676
Citation
Wenger N, Moraud EM, Raspopovic S, Bonizzato M, DiGiovanna J, Musienko P, Morari M, Micera S, Courtine G. Closed-loop neuromodulation of spinal sensorimotor circuits controls refined locomotion after complete spinal cord injury. Sci Transl Med. 2014 Sep 24;6(255):255ra133. doi: 10.1126/scitranslmed.3008325.
Results Reference
background
PubMed Identifier
24187327
Citation
Vallery H, Lutz P, von Zitzewitz J, Rauter G, Fritschi M, Everarts C, Ronsse R, Curt A, Bolliger M. Multidirectional transparent support for overground gait training. IEEE Int Conf Rehabil Robot. 2013 Jun;2013:6650512. doi: 10.1109/ICORR.2013.6650512.
Results Reference
background
PubMed Identifier
24796441
Citation
Swinnen E, Baeyens JP, Pintens S, Van Nieuwenhoven J, Ilsbroukx S, Buyl R, Ron C, Goossens M, Meeusen R, Kerckhofs E. Trunk kinematics during walking in persons with multiple sclerosis: the influence of body weight support. NeuroRehabilitation. 2014;34(4):731-40. doi: 10.3233/NRE-141089.
Results Reference
background
PubMed Identifier
24021298
Citation
Ganesan M, Sathyaprabha TN, Gupta A, Pal PK. Effect of partial weight-supported treadmill gait training on balance in patients with Parkinson disease. PM R. 2014 Jan;6(1):22-33. doi: 10.1016/j.pmrj.2013.08.604. Epub 2013 Sep 8.
Results Reference
background
PubMed Identifier
12370870
Citation
Miyai I, Fujimoto Y, Yamamoto H, Ueda Y, Saito T, Nozaki S, Kang J. Long-term effect of body weight-supported treadmill training in Parkinson's disease: a randomized controlled trial. Arch Phys Med Rehabil. 2002 Oct;83(10):1370-3. doi: 10.1053/apmr.2002.34603.
Results Reference
background
PubMed Identifier
12770637
Citation
Threlkeld AJ, Cooper LD, Monger BP, Craven AN, Haupt HG. Temporospatial and kinematic gait alterations during treadmill walking with body weight suspension. Gait Posture. 2003 Jun;17(3):235-45. doi: 10.1016/s0966-6362(02)00105-4.
Results Reference
background
PubMed Identifier
27282960
Citation
Dragunas AC, Gordon KE. Body weight support impacts lateral stability during treadmill walking. J Biomech. 2016 Sep 6;49(13):2662-2668. doi: 10.1016/j.jbiomech.2016.05.026. Epub 2016 Jun 1.
Results Reference
background
PubMed Identifier
20855074
Citation
Lewek MD. The influence of body weight support on ankle mechanics during treadmill walking. J Biomech. 2011 Jan 4;44(1):128-33. doi: 10.1016/j.jbiomech.2010.08.037. Epub 2010 Sep 19.
Results Reference
background
PubMed Identifier
28724575
Citation
Mignardot JB, Le Goff CG, van den Brand R, Capogrosso M, Fumeaux N, Vallery H, Anil S, Lanini J, Fodor I, Eberle G, Ijspeert A, Schurch B, Curt A, Carda S, Bloch J, von Zitzewitz J, Courtine G. A multidirectional gravity-assist algorithm that enhances locomotor control in patients with stroke or spinal cord injury. Sci Transl Med. 2017 Jul 19;9(399):eaah3621. doi: 10.1126/scitranslmed.aah3621.
Results Reference
background
Learn more about this trial
LEAP a New Overground Body Weight Support Robot: Usability Trial
We'll reach out to this number within 24 hrs